Liu Y - Search Results

1

Mussel-Inspired Biocoating for Improving the Adhesion of Dental Pulp Stem Cells in Dental Pulp Regeneration.

Liu Y, Qiu Y, Ni S, Zhang X, Sun H, Song W, Li X. Liu Y, et al. Macromol Rapid Commun. 2020 Dec;41(24):e2000102. doi: 10.1002/marc.202000102. Epub 2020 Jun 2. Macromol Rapid Commun. 2020. PMID: 32483838

2

Enhanced osteogenic healing process of rat tooth sockets using a novel simvastatin-loaded injectable microsphere-hydrogel system.

Li X, Liu X, Ni S, Liu Y, Sun H, Lin Q. Li X, et al. Among authors: liu y, liu x. J Craniomaxillofac Surg. 2019 Jul;47(7):1147-1154. doi: 10.1016/j.jcms.2019.04.011. Epub 2019 Apr 24. J Craniomaxillofac Surg. 2019. PMID: 31078372 Free article.

3

Zinc cooperates with p53 to inhibit the activity of mitochondrial aconitase through reactive oxygen species accumulation.

Xue YN, Liu YN, Su J, Li JL, Wu Y, Guo R, Yu BB, Yan XY, Zhang LC, Sun LK, Li Y. Xue YN, et al. Among authors: liu yn. Cancer Med. 2019 May;8(5):2462-2473. doi: 10.1002/cam4.2130. Epub 2019 Apr 10. Cancer Med. 2019. PMID: 30972978 Free PMC article.

4

p62 aggregates mediated Caspase 8 activation is responsible for progression of ovarian cancer.

Yan XY, Zhong XR, Yu SH, Zhang LC, Liu YN, Zhang Y, Sun LK, Su J. Yan XY, et al. Among authors: liu yn. J Cell Mol Med. 2019 Jun;23(6):4030-4042. doi: 10.1111/jcmm.14288. Epub 2019 Apr 2. J Cell Mol Med. 2019. PMID: 30941888 Free PMC article.

5

ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.

Xu Y, Gao W, Zhang Y, Wu S, Liu Y, Deng X, Xie L, Yang J, Yu H, Su J, Sun L. Xu Y, et al. Among authors: liu y. Int J Oncol. 2018 Sep;53(3):1055-1068. doi: 10.3892/ijo.2018.4476. Epub 2018 Jul 9. Int J Oncol. 2018. PMID: 30015875 Free PMC article.

6

Inhibition of TIGAR Increases Exogenous p53 and Cisplatin Combination Sensitivity in Lung Cancer Cells by Regulating Glycolytic Flux.

Fu J, Yu S, Zhao X, Zhang C, Shen L, Liu Y, Yu H. Fu J, et al. Among authors: liu y. Int J Mol Sci. 2022 Dec 16;23(24):16034. doi: 10.3390/ijms232416034. Int J Mol Sci. 2022. PMID: 36555672 Free PMC article.

7

p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.

Yan XY, Zhang Y, Zhang JJ, Zhang LC, Liu YN, Wu Y, Xue YN, Lu SY, Su J, Sun LK. Yan XY, et al. Among authors: liu yn. Cancer Sci. 2017 Jul;108(7):1405-1413. doi: 10.1111/cas.13276. Epub 2017 Jun 25. Cancer Sci. 2017. PMID: 28498503 Free PMC article.

8

Androgen receptor splicing variant 7 (ARv7) promotes DNA damage response in prostate cancer cells.

Luo H, Liu Y, Li Y, Zhang C, Yu B, Shao C. Luo H, et al. Among authors: liu y. FASEB J. 2022 Sep;36(9):e22495. doi: 10.1096/fj.202200190R. FASEB J. 2022. PMID: 35947121

9

Enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfecting the attenuated Salmonella carrying a plasmid co-expressing p53 gene and mdm2 siRNA.

Jiang T, Zhou C, Gu J, Liu Y, Zhao L, Li W, Wang G, Li Y, Cai L. Jiang T, et al. Among authors: liu y. Cancer Lett. 2013 Aug 28;337(1):133-42. doi: 10.1016/j.canlet.2013.05.028. Epub 2013 May 29. Cancer Lett. 2013. PMID: 23726840

10

The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer.

Deng X, Lin N, Fu J, Xu L, Luo H, Jin Y, Liu Y, Sun L, Su J. Deng X, et al. Among authors: liu y. Oxid Med Cell Longev. 2020 Nov 26;2020:4830418. doi: 10.1155/2020/4830418. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33294122 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,791 results

Search Page

Filters